Iron and Volume in the Deep Gray Matter: Association with Cognitive Impairment in Multiple Sclerosis

References

1. 1.↵
   2. Craelius W,
   3. Migdal MW,
   4. Luessenhop CP, et al

   . Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med 1982;106:397–99

   PubMedWeb of Science
2. 2.↵
   2. LeVine SM,
   3. Lynch SG,
   4. Ou CN, et al

   . Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients. Brain Res 1999;821:511–15

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Williams R,
   3. Buchheit CL,
   4. Berman NE, et al

   . Pathogenic implications of iron accumulation in multiple sclerosis. J Neurochem 2012;120:7–25

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Haacke EM,
   3. Xu Y,
   4. Cheng YC, et al

   . Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52:612–18

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Zivadinov R,
   3. Heininen-Brown M,
   4. Schirda CV, et al

   . Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study. Neuroimage 2012;59:331–39

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Hagemeier J,
   3. Weinstock-Guttman B,
   4. Bergsland N, et al

   . Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy. AJNR Am J Neuroradiol 2012;33:1596–601

   Abstract/FREE Full Text
7. 7.↵
   2. Hagemeier J,
   3. Yeh EA,
   4. Brown MH, et al

   . Iron content of the pulvinar nucleus of the thalamus is increased in adolescent multiple sclerosis. Mult Scler 2013;19:567–76

   Abstract/FREE Full Text
8. 8.↵
   2. Al-Radaideh AM,
   3. Wharton SJ,
   4. Lim SY, et al

   . Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in clinically isolated syndrome. Mult Scler 2013;19:896–903

   Abstract/FREE Full Text
9. 9.↵
   2. Zivadinov R,
   3. Sepcic J,
   4. Nasuelli D, et al

   . A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;70:773–80

   Abstract/FREE Full Text
10. 10.↵
    2. Benedict RH,
    3. Weinstock-Guttman B,
    4. Fishman I, et al

    . Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 2004;61:226–30

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Fisher E,
    3. Lee JC,
    4. Nakamura K, et al

    . Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 2008;64:255–65

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Benedict RH,
    3. Schwartz CE,
    4. Duberstein P, et al

    . Influence of personality on the relationship between gray matter volume and neuropsychiatric symptoms in multiple sclerosis. Psychosom Med 2013;75:253–61

    Abstract/FREE Full Text
13. 13.↵
    2. Batista S,
    3. Zivadinov R,
    4. Hoogs M, et al

    . Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J Neurol 2012;259:139–46

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Schoonheim MM,
    3. Popescu V,
    4. Rueda Lopes FC, et al

    . Subcortical atrophy and cognition: sex effects in multiple sclerosis. Neurology 2012;79:1754–61

    CrossRefPubMed
15. 15.↵
    2. Bergsland N,
    3. Horakova D,
    4. Dwyer MG, et al

    . Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 2012;33:1573–78

    Abstract/FREE Full Text
16. 16.↵
    2. Aubert-Broche B,
    3. Fonov V,
    4. Ghassemi R, et al

    . Regional brain atrophy in children with multiple sclerosis. NeuroImage 2011;58:409–15

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Calabrese M,
    3. Rinaldi F,
    4. Grossi P, et al

    . Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis. Mult Scler 2010;16:1220–28

    Abstract/FREE Full Text
18. 18.↵
    2. Hagemeier J,
    3. Weinstock-Guttman B,
    4. Heininen-Brown M, et al

    . Gray matter SWI-filtered phase and atrophy are linked to disability in MS. Front Biosci (Elite Ed) 2013;5:525–32

    PubMed
19. 19.↵
    2. Polman CH,
    3. Reingold SC,
    4. Edan G, et al

    . Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria.” Ann Neruol 2005;58:840–46

    CrossRef
20. 20.↵
    2. Zivadinov R,
    3. Rudick RA,
    4. De Masi R, et al

    . Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS. Neurology 2001;57:1239–47

    CrossRef
21. 21.↵
    2. Patenaude B,
    3. Smith SM,
    4. Kennedy DN, et al

    . A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011;56:907–22

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Hagemeier J,
    3. Dwyer MG,
    4. Bergsland N, et al

    . Effect of age on MRI phase behavior in the subcortical deep gray matter of healthy individuals. AJNR Am J Neuroradiol 2013;34:2144–51

    Abstract/FREE Full Text
23. 23.↵
    2. Benedict RH,
    3. Fischer JS,
    4. Archibald CJ, et al

    . Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol 2002;16:381–97

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Smith A

    . Symbol Digit Modality Test Manual. Los Angeles: Western Psychological Services; 1982
25. 25.↵
    2. Gronwall DM

    . Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills 1977;44:367–73

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Delis DC,
    3. Kaplan E,
    4. Kramer JH

    . Delis-Kaplan Executive Function System (D-KEFS): New York: Psychological Corporation; 2001
27. 27.↵
    2. Delis DC,
    3. Kramer JH,
    4. Kaplan E, et al

    . California Verbal Learning Test. 2nd ed. San Antonio: Psychological Corporation; 2000
28. 28.↵
    2. Benedict R

    . Brief Visuospatial Memory Test-Revised. Odessa, Florida: Psychological Assessment Resources; 1997
29. 29.↵
    2. Benedict RH,
    3. Cookfair D,
    4. Gavett R, et al

    . Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 2006;12:549–58

    PubMedWeb of Science
30. 30.↵
    2. Benedict RH,
    3. Bruce JM,
    4. Dwyer MG, et al

    . Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. Arch Neurol 2006;63:1301–06

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Khalil M,
    3. Langkammer C,
    4. Ropele S, et al

    . Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study. Neurology 2011;77:1691–97

    CrossRef
32. 32.↵
    2. Brass SD,
    3. Benedict RH,
    4. Weinstock-Guttman B, et al

    . Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler 2006;12:437–44

    Abstract/FREE Full Text
33. 33.↵
    2. Haacke EM,
    3. Miao Y,
    4. Liu M, et al

    . Correlation of putative iron content as represented by changes in R2* and phase with age in deep gray matter of healthy adults. J Magn Reson Imaging 2010;32:561–76

    CrossRefPubMed
34. 34.↵
    2. Schenker C,
    3. Meier D,
    4. Wichmann W, et al

    . Age distribution and iron dependency of the T2 relaxation time in the globus pallidus and putamen. Neuroradiology 1993;35:119–24

    CrossRefPubMedWeb of Science
35. 35.↵
    2. Ge Y,
    3. Jensen J,
    4. Lu H, et al

    . Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol 2007;28:1639–44

    Abstract/FREE Full Text
36. 36.↵
    2. Hu CJ,
    3. Jensen H,
    4. Williams K, et al

    . Comparison of susceptibility-weighted imaging and magnetic field correlation imaging. Proc Int Soc Mag Reson Med 2009;17:4524
37. 37.↵
    2. Kovtunovych G,
    3. Eckhaus MA,
    4. Ghosh MC, et al

    . Dysfunction of the heme recycling system in heme oxygenase 1-deficient mice: effects on macrophage viability and tissue iron distribution. Blood 2010;116:6054–62

    Abstract/FREE Full Text
38. 38.↵
    2. Arnsten AF,
    3. Rubia K

    . Neurobiological circuits regulating attention, cognitive control, motivation, and emotion: disruptions in neurodevelopmental psychiatric disorders. J Am Acad Child Adolesc Psychiatry 2012;51:356–67

    CrossRefPubMed
39. 39.↵
    2. Cotton PL,
    3. Smith AT

    . Contralateral visual hemifield representations in the human pulvinar nucleus. J Neurophysiol 2007;98:1600–09

    Abstract/FREE Full Text